Pricing and reimbursement analysis of bacillus calmette-guerin (BCG) immunotherapy for bladder cancer

dc.creator	Bekčić, Stana
dc.creator	Mitrović, I.
dc.creator	Baltezarević, D.
dc.creator	Radojević, V.
dc.creator	Samardžić, J.
dc.creator	Milenković, V.
dc.date.accessioned	2021-02-18T10:42:57Z
dc.date.available	2021-02-18T10:42:57Z
dc.date.issued	2014
dc.identifier.issn	1098-3015
dc.identifier.uri	http://intor.torlakinstitut.com/handle/123456789/408
dc.publisher	Elsevier Science Inc, New York
dc.rights	openAccess
dc.source	Value in Health
dc.title	Pricing and reimbursement analysis of bacillus calmette-guerin (BCG) immunotherapy for bladder cancer	en
dc.type	conferenceObject
dc.rights.license	ARR
dc.citation.epage	A654
dc.citation.issue	7
dc.citation.other	17(7): A654-A654
dc.citation.rank	aM21
dc.citation.spage	A654
dc.citation.volume	17
dc.identifier.doi	10.1016/j.jval.2014.08.2385
dc.identifier.fulltext	http://intor.torlakinstitut.com/bitstream/id/242/405.pdf
dc.identifier.pmid	27202366
dc.identifier.wos	000346917302419
dc.type.version	publishedVersion